- $965.60m
- $937.62m
- $3.86m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.164 | 0.569 | 0.763 | 3.93 | 3.86 |
Cost of Revenue | |||||
Gross Profit | -5.52 | -7.2 | -17.6 | -7.88 | -8.88 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 17.4 | 30 | 43.2 | 69.5 | 67.4 |
Operating Profit | -17.3 | -29.5 | -42.4 | -65.5 | -63.5 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -18.3 | -137 | -145 | -40.1 | -71.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -18.3 | -137 | -145 | -40.1 | -71.7 |
Net Income Before Extraordinary Items | |||||
Net Income | -18.3 | -137 | -145 | -40.1 | -71.7 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -98.8 | -170 | -158 | -40.1 | -71.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.03 | -1.78 | -1.66 | -0.397 | -0.664 |
Dividends per Share |